Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1292 of 6351
-
Can an immune booster make CAR-T therapy last longer in myeloma?
Disease control Recruiting nowCAR-T cell therapy is an emerging treatment modality in relapsed and refractory multiple myeloma (MM). CAR-T therapy in MM relies on directing autologous T-cells to detect and clear myeloma cells expressing B-cell Maturation Antigen (BCMA). While BCMA CAR-T cell-treated patients …
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New nose spray could help diabetic eye disease when shots fail
Disease control Not yet recruitingTreatment of diabetic retinopathy (DR) and diabetic macula edema has included panretinal photocoagulation and intra ocular injections of anti-vascular endothelial growth factors (anti-VEGF) agents and steroids. Anti-VEGF therapy is currently the first-line treatment for prolifera…
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New cell therapy B019 takes on tough lymphoma in first human trial
Disease control Not yet recruitingThe purpose of the study is to evaluate the safety、tolerability and preliminary efficacy of B019 in subjects with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Phase 1 • Sponsor: Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for colorectal cancer: immune booster plus chemotherapy tested
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the superiority of ivonescimab combined with FOLFIRI over FOLFIRI + bevacizumab as second-line treatment of non resectable pMMR/MSS BRAFwt mCRC patients without liver metastases in terms of PFS. The main questions it aims to answer a…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Cancer-Killing virus trial launches for melanoma that spread to brain
Disease control Not yet recruitingThe goal of this clinical research study is to find the recommended dose level and recommended number of injections of the study agent DNX-2401 that can be given to patients with metastatic melanoma that have intracranial and/or extracranial lesions.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New program aims to restore sexual function after prostate cancer surgery
Disease control Recruiting nowProstate cancer is the most common cancer in Australian men. Robot-assisted radical prostatectomy (RARP) - surgical removal of the prostate - is a standard treatment, but it frequently causes erectile dysfunction (ED) and urinary incontinence that can persist for years and signif…
Phase 2 • Sponsor: Surgical Outcomes Research Centre (SOuRCe) • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Steam therapy aims to zap prostate cancer without major surgery
Disease control Not yet recruitingThe goal of this study is to evaluate the safety and effectiveness of the Vanquish Water Vapor Ablation System ("Vanquish") in participants with Grade Group 3 (GG3) intermediate-risk prostate cancer. Participants will undergo therapy with the Vanquish System and complete follow …
Sponsor: Francis Medical Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New scan could sharpen detection of head and neck cancers
Diagnosis Not yet recruitingThis is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patients with head and neck squamous cell carcinoma (HNSCC).
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
New clot-sucking device tested in real-world vein clot treatment
Disease control Not yet recruitingThe objective of this study is to evaluate how well and how safe the FLOWRUNNER Aspiration System works for treating blood clots in the arms or legs in real-life medical settings.
Sponsor: FlowPhysix, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a new pill help men last longer? a trial puts VV913 to the test
Symptom relief Not yet recruitingThis trial adopted a multicenter, randomized, double-blind, placebo-controlled design and consisted of two parts: Part Ⅰ and Part Ⅱ.
Phase 2 • Sponsor: Vigonvita Life Sciences • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Could a prostate drug stop shoulder infections before they start?
Disease control Not yet recruitingHigh levels of Testosterone causes high amounts of skin bacteria (Cutibacterium Acnes) which can go into the skin during a shoulder replacement surgery and cause a terrible infection. The goal of this experiment is to have participants take Finasteride, a medication that blocks …
Phase 4 • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A swallowable spy pill could unlock Sjögren's secrets
Knowledge-focused Not yet recruitingThe goal of this observational study is to characterize and compare region-specific gastrointestinal, stool, oral, and periodontal microbiomes in adults with Sjögren's disease and healthy controls using ingestible mini-pill sampling technology. The study will include adults with …
Sponsor: Tufts University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Fasting in the ICU: a metabolic key to immune response?
Knowledge-focused Not yet recruitingKETO-FAST is a pre-planned translational substudy of the FAST-ICU cluster-randomized cross-over trial. The substudy will characterize ketone body production and associated metabolic, autophagy-related, and immune cellular responses during the first 72 hours after intensive care u…
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
DNA clues could forecast steroid relapse in PMR
Knowledge-focused Not yet recruitingPolymyalgia Rheumatica (PMR) is treated with corticosteroids; however, long-term treatment is not feasible due to side effects. Withdrawal of corticosteroids causes a subset of patients to relapse, and there is no current way to understand what underlies this. Our research team h…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Can a new formulation of an endometriosis drug match the standard?
Disease control Recruiting nowThe goal of this clinical trial is to find out how the study drug HHK001 compares to Enantone (an approved treatment for endometriosis) when given as a single 3.75 mg injection to participants with endometriosis. Both products contain the same active ingredient: leuprorelin aceta…
Phase 1 • Sponsor: Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can an extra ligament repair make shoulder stabilization surgery more effective?
Disease control Not yet recruitingThis pilot study aims to explore the feasibility and relevance of comparing the open Latarjet procedure performed with and without capsular repair (via coracoacromial ligament transfer) in patients with recurrent anterior shoulder instability. It will also generate preliminary da…
Sponsor: Clinique Générale dAnnecy • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
A drop of blood, a Minute's wait: rapid blood typing put to the test
Diagnosis Not yet recruitingCLS-019A is a prospective, multi-site, parallel clinical performance study. Each enrolled subject is tested on both investigational devices in parallel within a single study visit, yielding paired INSTI® and TruPlex results from matched capillary fingerstick and EDTA-VWB samples.…
Sponsor: bioLytical Laboratories • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
Could a Joint-Lubricant injection ease stubborn back pain?
Symptom relief Not yet recruitingTo determine whether the addition of sodium hyaluronate to standard ultrasoundguided lidocaine injection provides superior and sustained pain relief compared with standard lidocaine injection alone in patients with suspected myofascial or nonspecific thoracic back pain.
Sponsor: EPC Education s.r.o. • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can a new injection outlast the standard endometriosis treatment?
Disease control Not yet recruitingThis study compares the pharmacokinetics/pharmacodynamics (PK/PD), safety, and preliminary efficacy of a single 3.75 mg dose of HHK001 (Leuprorelin Acetate Microspheres for Injection, an improved formulation) versus Enantone (Leuprorelin Acetate Microspheres for Injection) in pat…
Phase 1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a primary care therapy ease trauma in children?
Symptom relief Not yet recruitingThe purpose of this study is to evaluating the feasibility of delivering a trauma-focused intervention among children with elevated traumatic stress symptoms in primary care
Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC